Case Note: H Lundbeck A/S & Anor v Sandoz Pty Ltd
A recent decision of the Federal Court of Australia has demonstrated that the launch of a pharmaceutical product by a generic company even after expiry of the standard term...
A recent decision of the Federal Court of Australia has demonstrated that the launch of a pharmaceutical product by...
Read More
Sigma Pharmaceuticals Case Clarifies Aspects of Compensable Loss
The recent decision in Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth FCA 1556 has clarified, among other things, a number of issues concerning compensation arising from the usual...
The recent decision in Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth FCA 1556 has clarified, among other things,...
Read More
Pat-INFORMED: A powerful new searching tool, but don’t be left Part-INFORMED
A new database has been launched with the principal purpose of providing easily accessible and understandable information about the patent status of a specific medicine in a particular country,...
A new database has been launched with the principal purpose of providing easily accessible and understandable information about the...
Read More
The “gene patent” dichotomy between the US and Australia
The recent Meat & Livestock Australia Limited v Cargill, Inc (MLA) Federal Court decision has brought the significant differences that exist between Australian and US “gene patent” practice into sharp focus. These differences...
The recent Meat & Livestock Australia Limited v Cargill, Inc (MLA) Federal Court decision has brought the significant differences that exist between Australian...
Read More
Australia remains a gene-patent friendly jurisdiction
When the Australian High Court ruled against the patentability of isolated naturally occurring genes in the Myriad decision, a number of commentators believed that the decision would ultimately invalidate...
When the Australian High Court ruled against the patentability of isolated naturally occurring genes in the Myriad decision, a...
Read More
Pfizer succeeds in Full Federal Court appeal and will now receive preliminary discovery regarding possible infringement of biological medicine process patents
We previously reported on the 21 March 2017 decision of Burley J of the Federal Court of Australia in Pfizer Ireland Pharmaceuticals v Samsung Bioepis AU Pty Ltd  FCA 285, in which...
We previously reported on the 21 March 2017 decision of Burley J of the Federal Court of Australia in Pfizer Ireland Pharmaceuticals...
Read More
The Patent Office provides clarity regarding enablement of polypeptide claims
Australia has relatively recently implemented support laws that require a specification to provide sufficient information to enable the skilled person to perform an invention over the entire scope of the claims...
Australia has relatively recently implemented support laws that require a specification to provide sufficient information to enable the skilled person to...
Read More